US 9885045
Methods and compositions for modulating apolipoprotein (a) expression
granted A61PA61P29/00A61P3/00
Quick answer
US patent 9885045 (Methods and compositions for modulating apolipoprotein (a) expression) held by Ionis Pharmaceuticals, Inc. expires Mon Feb 01 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Ionis Pharmaceuticals, Inc.
- Grant date
- Tue Feb 06 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 01 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61P, A61P29/00, A61P3/00, A61P9/00, A61P9/10